LHC-165
LHC-165 is a TLR7 agonist. LHC-165 has potential to used in study of solid tumors[1][2].
Product Specifications
CAS Number
1258595-14-0
UNSPSC
12352005
Target
Toll-like Receptor (TLR)
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Neuroscience-Neuromodulation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/LHC-165.html
Purity
98.0
Smiles
NC1=C2C(C=C(CCC3=CC=C(OCCOCCC(F)(F)P(O)(O)=O)C=C3C)C=N2)=C4C(C=C(CCC(O)=O)C=C4)=N1
Molecular Formula
C29H32F2N3O7P
Molecular Weight
603.55
References & Citations
[1]Carole Bourquin, et al. Harnessing the immune system to fight cancer with Toll-like receptor and RIG-I-like receptor agonists. Pharmacological Research. 2019 Mar.|[2]LHC165.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
TLR7
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![2-Chloro-N-(4'-chloro-5-hydroxy[1,1'-biphenyl]-2-yl)-3-pyridinecarboxamide](https://cdn.genprice.uk/products/572/4385817751175/imageurl/trc-c587855-10mg.webp)
TRC-C587855-10MG 10 mg
2-Chloro-N-(4'-chloro-5-hydroxy[1,1'-biphenyl]-2-yl)-3-pyridinecarboxamide
Sign In for Pricing
View Details 
BNC681129-500 1x 500 µL
MHC II (HLA-DP) (beta chain) (Bra-14), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 